Stock Market & Financial News
Schwab's Prediction Market Push: What Investors Should Know
SCHW plans to launch S&P 500-linked prediction market contracts with Cboe. This will likely broaden retail trading options and strengthen the platform's appeal.
SCHW Summit Therapeutics: High-Volatility, Catalyst-Driven Binary Bet
Summit Therapeutics is a highly volatile, single-asset company with a binary outcome. SMMT exhibits unusually concentrated ownership and heightened short interest, creating conditions for a short squeeze to take place. Recent pullbacks, driven by mixed market receptions to events do not fundamentally alter the investment narratives, present investors with an attractive entry point ahead of key catalysts.
SMMT EUR/USD forecast: Currency Pair of the Week | June 22, 2026
The euro started the week on a softer footing against the dollar, surrendering part of Friday's rebound as investors continued to digest last week's shift in Federal Reserve messaging. Although the EUR/USD managed to stabilise towards the end of the previous week, the overall backdrop remains supportive for the dollar after policymakers at the Fed signalled a more hawkish policy outlook than markets had anticipated, with markets now pricing some 40-45 basis points of hikes by the end of the year.
Bitmine added $92 million of ETH, with Tom Lee continuing to believe in 'crypto spring'
The largest Ethereum treasury firm slowed its buying pace but remains on track to reach its goal of owning 5% of ETH supply.
Strive acquires 759 Bitcoin for $50M, growing its treasury to 19,000 BTC
Strive's aggressive Bitcoin acquisition strategy heightens its exposure to market volatility, posing significant risks to its financial stability. Strive acquires 759 Bitcoin for $50M, growing its treasury to 19,000 BTC.
Blockmate Ventures targets up to $1M through private placement to support Wyoming AI project
Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF, FRA:8MH) announced that it plans to complete a non-brokered private placement to raise gross proceeds of up to $750,000, with the possibility of increasing the total amount to as much as $1 million through oversubscriptions. The offering will consist of up to 15 million units priced at $0.05 each.
MATEF 
Strategy adds $35M in Bitcoin, $300M in cash reserves last week
Strategy's aggressive Bitcoin accumulation could amplify financial risk, relying heavily on BTC's market performance to justify equity dilution. Strategy adds $35M in Bitcoin, $300M in cash reserves last week.
Warsh, SpaceX & Iran Rule Last Week: 5 Leveraged ETF Winners
Warsh's Fed debut, SpaceX's AI deal and Iran headlines fueled a risk-on rally. These 5 leveraged ETFs soared as much as 94% last week.
WNRS 
Apple stock hit with major Wall Street downgrade
Apple (NASDAQ: AAPL) shares have been hit with a notable Wall Street downgrade after KGI Securities lowered its rating on the technology giant from ‘Outperform' to ‘Neutral', citing limited upside potential following the stock's strong recent rally.
AAPL 
SiTime: This AI Inflection Isn't Priced In
Revenue surged 88% to $113.6 million while AI-focused CED revenue jumped 158% and reached two-thirds of sales. Management raised full-year growth guidance to at least 80%, signaling stronger visibility and accelerating AI infrastructure demand. Gross margin expanded to 64.5%, operating margin reached 28%, and operating cash flow more than doubled year-over-year.
SITM 
Taiko Sounds the Alarm After Bridge Exploit Drains $1.7M in Unauthorized Withdrawals
Taiko urged users to withdraw from all bridges after a chain state verification compromise enabled unauthorized bridge withdrawals. Attackers used forged withdrawal proofs or messages that were accepted on Ethereum without matching legitimate activity on Taiko, draining up to $1.7 million.
Ethena price prediction: Can 7-month high network activity fuel ENA's breakout?
Traders remain bullish even as large holders increase downside bets.
UPS to invest $48 million in temperature-controlled facilities amid healthcare boom
UPS is announcing a new investment in healthcare logistics as demand for the temperature-controlled category booms, CNBC has learned exclusively. The $48 million investment will go toward improving 27 temperature-controlled facilities across its domestic and international businesses.
UPS 
Alibaba: Technical Bottom Is Near - Diversified Commerce/Cloud Growth Prospects
Alibaba's aggressive investments in quick commerce/fulfillment capabilities have driven accelerated double digits revenue growth against the mature e-commerce segment, albeit pressuring EBITA margins. The same has been observed in the AI/cloud capabilities and the higher capex trends triggering the negative Free Cash Flow generation, albeit mitigated by the rich balance sheet. These headwinds have contributed to BABA's overly done meltdown and discounted P/E of 15.92x, with the stock now offering a more than doubling upside potential to my LTPT of $277.80.
BABA 
SPYI: I'm Still Bullish, And This Time Volatility Is Doing The Work
NEOS S&P 500 High Income ETF (SPYI) has surpassed $10B AUM, driven by strong inflows and investor demand for high-yield income solutions. SPYI's two-leg options strategy enables robust monthly distributions (11.86% yield) while retaining partial upside, outperforming peers JEPI and XYLD since inception. The ETF's tax-efficient structure, blending Section 1256 contracts and return of capital, enhances after-tax income for taxable investors.
SPYI 
Microsoft Won't Be This Cheap For Long
Microsoft is still rated as a Strong Buy as valuation nears five-year lows and the long-term uptrend remains intact, demonstrating tremendous resilience. MSFT faces heightened AI-driven competitive threats, but its integrated software stack and robust free cash flow margins provide robust defense. AI monetization is nascent, and Copilot seat adoption and more cost-efficient models could drive future upside, especially as token-maxxing pressures mount.
MSFT 
5 Things to Know Before the Stock Market Opens
Stocks are having a quiet morning Monday as investors come off a long holiday weekend with a close eye on peace talks between the U.S. and Iran; a second day of negotiations in Switzerland has reportedly concluded after renewed threats against Iran from President Trump and continued attacks in Lebanon by Israel made for an eventful first day of talks; earnings from FedEx and Micron are on tap this week, along with the release of the Fed's preferred measure of inflation; SpaceX shares are poised to start this week with a third straight day of declines; and shares of Apogee Therapeutics are soaring on news it is being acquired by AbbVie for $11 billion. Here's what you need to know today.
ABBV 
Here is the SpaceX share unlock timeline
The first week of SpaceX's (NASDAQ: SPCX) public journey has wrapped with the stock up 15%, and now all eyes are on the SpaceX share unlock timeline.
SPCX 
Howmet Aerospace: Powerful Nexus Of Secular Trends
Howmet Aerospace (HWM) earns a 'Strong Buy' rating for its critical role in both the aerospace and AI infrastructure value chains. HWM commands a dominant market position, outpacing domestic competitors in aerospace revenue growth and leveraging a vast IP portfolio. The company is a key supplier to global gas turbine leaders, positioning HWM to benefit from sustained AI-driven energy demand and supply constraints.
HWM 
Oracle vs. Penguin Solutions: Which AI Data Center Stock Is a Buy?
PENG tops ORCL in this AI infrastructure faceoff, backed by AI/HPC momentum, memory growth and lower capital intensity.
ORCL 
Hercules Capital Faces Its Own 12 Labors
Hercules Capital is trading at a 30% premium to NAV, down from 72% in 2024, reflecting compressed sentiment around technology-focused BDCs. HTGC is paying out a 12.1% dividend yield, with a $0.40 base and a $0.07 supplemental quarterly dividend. The base dividend was 120% covered by first-quarter net investment income. Portfolio credit quality remains robust, with nonaccruals at fair value at just 0.1% of the total investment portfolio as of the end of the first quarter.
HTGC 
GeneDx: Why I Think The Selloff Went Too Far
GeneDx shares have collapsed 65% since November, but I assign a buy rating due to strong volume growth and undervaluation versus peers. Despite a 34% YoY volume increase, revenue growth lagged at 27% due to lower reimbursement rates from a shift to genome testing. WGS owns one of the largest rare disease genomic databases, creating a durable competitive advantage and potential for AI-driven value creation.
WGS 
Analyst initiates 12-month coverage of SpaceX stock
Amid the ongoing correction for Space Exploration Technologies Corp. (NASDAQ: SPCX) stocks, KeyBanc has initiated coverage of SpaceX stock for the next 12 months.
SPCX 
Taiko's $1.7 Million Hack Shuts Down Block Production on Ethereum Layer 2
Taiko is down. The Ethereum layer 2 network halted block production after hackers drained roughly $1.
Bitcoin mining network becoming more sensitive to price swings, JPMorgan says
A growing share of miners are operating near breakeven levels, making hashrate and mining difficulty increasingly responsive to bitcoin's price movements, the bank said.
Ethereum Faces Fierce Backlash Over Proposal to Redirect Staking Rewards
Ethereum validators could redirect 0% to 10% of staking rewards toward ecosystem projects under the validator redirected revenue proposal. If most validators support a nonzero rate, the redirect becomes mandatory for all validators and could send 50,000 to 70,000 ETH annually into funding.
Pembina Pipeline: Energy Security Is Becoming A Bigger Growth Driver
Pembina Pipeline remains a buy, targeting a $53.55 price and 16% upside, supported by stable cash flows and strategic project development. PBA maintains 5%-7% annual EBITDA per share growth guidance through 2030, driven by asset utilization and sanctioned projects amid an evolving fee-based revenue mix. Q1 results showed a 3.9% revenue decline to C$1.29B, but facilities EBITDA grew; pipeline revenues were impacted by Alliance Pipeline's new toll structure.
PBA 
Can Analog Devices Sustain Margin Expansion Throughout 2026?
ADI's margins keep climbing as Industrial, Data Center and Communications growth boost high-value revenues and operating leverage into 2027.
ADI 
HIVE Digital Technologies reports successful AI training trial using Paraguay-based GPUs
HIVE Digital Technologies Ltd (TSX:HIVE, NASDAQ:HIVE, FRA:YO0, BVC:HIVECO) announced that it has completed its first artificial intelligence research project using graphics processing units (GPUs) in Paraguay in collaboration with Columbia University's Department of Industrial Engineering and Operations Research. The company said the research has been submitted to the Conference on Neural Information Processing Systems (NeurIPS), a major annual conference focused on machine learning and computational neuroscience.
HIVE 
Novo Nordisk's Wegovy pill headlines mask complicated competitive reality
Novo Nordisk's (NYSE:NVO) Wegovy pill is running three times ahead of rival Zepbound at the equivalent stage of launch, according to pharmacy data, a headline that implies dominant market positioning in oral GLP-1 therapeutics. But the data supporting that claim comes with substantial qualifications that tell a different story.
NVO 
